Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2008, Vol. 111, No. 2, pp. 688-698.
Prepublished online as a Blood First Edition Paper on October 10, 2007; DOI 10.1182/blood-2007-04-085787.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-04-085787v1
111/2/688    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanishi, Y.
Right arrow Articles by Kitamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanishi, Y.
Right arrow Articles by Kitamura, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 16, 2007
Accepted September 18, 2007

Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells

Yoshinori Yamanishi, Jiro Kitaura, Kumi Izawa, Takayuki Matsuoka, Toshihiko Oki, Yang Lu, Fumi Shibata, Satoshi Yamazaki, Hidetoshi Kumagai, Hideaki Nakajima, Mari Maeda-Yamamoto, Victor L.J. Tybulewicz, Toshiyuki Takai, and Toshio Kitamura*

The Division of Cellular Therapy, Advanced Clinical Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Laboratory of Stem Cell Therapy, Center for Experimental Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
National Institute of Vegetable and Tea Science, National Agriculture Research Organization, Shizuoka, Japan
Devision of Immune Cell Biology, National Institute for Medical Research, London, United Kingdom
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan

* Corresponding author; email: kitamura{at}ims.u-tokyo.ac.jp.

We have analyzed leukocyte mono-immunoglobulin (Ig)-like receptor 5 (LMIR5) as an activating receptor among paired LMIRs. Mouse LMIR5 (mLMIR5) is expressed in myeloid cells such as mast cells, granulocytes, macrophages, and dendritic cells. Crosslinking of transduced-mLMIR5 in bone marrow-derived mast cell (BMMC) caused activation events, including cytokine production, cell survival, degranulation, and adhesion to the extracellular matrix. mLMIR5 associated with DAP12 and to a lesser extent with DAP10, and mLMIR5-mediated functions of BMMC were strongly inhibited by DAP12 deficiency. Importantly, crosllinking of endogenous mLMIR5 induced Syk-dependent activation of fetal liver-derived mast cells. Unlike mLMIR5, crosslinking of human LMIR5 (hLMIR5) induced cytokine production of BMMC even in the absence of both DAP12 and DAP10, suggesting the existence of unidentified adaptors. Interestingly, hLMIR5 possessed a tyrosine residue (Y188) in the cytoplasmic region. Signaling via Y188 phosphorylation played a predominant role in hLMIR5-mediated cytokine production in DAP12-deficient, but not wild type BMMC. In addition, experiments using DAP10/DAP12 double-deficient BMMC suggested the existence of Y188 phoshorylation-dependent and independent signals from unidentified adaptors. Collectively, although both mouse and human LMIR5 play activatory roles in innate immunity cells, the functions of LMIR5 were differentially regulated in mouse versus human cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Izawa, J. Kitaura, Y. Yamanishi, T. Matsuoka, A. Kaitani, M. Sugiuchi, M. Takahashi, A. Maehara, Y. Enomoto, T. Oki, et al.
An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcR{gamma} in Mast Cells
J. Immunol., July 15, 2009; 183(2): 925 - 936.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. T. Orr, J. C. Sun, D. G.T. Hesslein, H. Arase, J. H. Phillips, T. Takai, and L. L. Lanier
Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection
J. Exp. Med., April 13, 2009; 206(4): 807 - 817.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020